These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure. Perin EC; Borow KM; Henry TD; Mendelsohn FO; Miller LW; Swiggum E; Adler ED; Chang DH; Fish RD; Bouchard A; Jenkins M; Yaroshinsky A; Hayes J; Rutman O; James CW; Rose E; Itescu S; Greenberg B J Am Coll Cardiol; 2023 Mar; 81(9):849-863. PubMed ID: 36858705 [TBL] [Abstract][Full Text] [Related]
14. Association of β-blocker therapy with risks of adverse cardiovascular events and deaths in patients with ischemic heart disease undergoing noncardiac surgery: a Danish nationwide cohort study. Andersson C; Mérie C; Jørgensen M; Gislason GH; Torp-Pedersen C; Overgaard C; Køber L; Jensen PF; Hlatky MA JAMA Intern Med; 2014 Mar; 174(3):336-44. PubMed ID: 24247428 [TBL] [Abstract][Full Text] [Related]
15. Catheter-based endomyocardial delivery of mesenchymal precursor cells using 3D echo guidance improves cardiac function in a chronic myocardial injury ovine model. Cheng Y; Yi G; Conditt GB; Sheehy A; Kolodgie FD; Tellez A; Polyakov I; Gu A; Aboodi MS; Wallace-Bradley D; Schuster M; Martens T; Itescu S; Kaluza GL; Basu S; Virmani R; Granada JF; Sherman W Cell Transplant; 2013; 22(12):2299-309. PubMed ID: 23107489 [TBL] [Abstract][Full Text] [Related]
16. A Combination of Allogeneic Stem Cells Promotes Cardiac Regeneration. Natsumeda M; Florea V; Rieger AC; Tompkins BA; Banerjee MN; Golpanian S; Fritsch J; Landin AM; Kashikar ND; Karantalis V; Loescher VY; Hatzistergos KE; Bagno L; Sanina C; Mushtaq M; Rodriguez J; Rosado M; Wolf A; Collon K; Vincent L; Kanelidis AJ; Schulman IH; Mitrani R; Heldman AW; Balkan W; Hare JM J Am Coll Cardiol; 2017 Nov; 70(20):2504-2515. PubMed ID: 29145950 [TBL] [Abstract][Full Text] [Related]
17. Rationale and Design of the CONCERT-HF Trial (Combination of Mesenchymal and c-kit Bolli R; Hare JM; March KL; Pepine CJ; Willerson JT; Perin EC; Yang PC; Henry TD; Traverse JH; Mitrani RD; Khan A; Hernandez-Schulman I; Taylor DA; DiFede DL; Lima JAC; Chugh A; Loughran J; Vojvodic RW; Sayre SL; Bettencourt J; Cohen M; Moyé L; Ebert RF; Simari RD; Circ Res; 2018 Jun; 122(12):1703-1715. PubMed ID: 29703749 [TBL] [Abstract][Full Text] [Related]
18. Allogeneic Precursor Cells for Systolic Heart Failure: A Need for Mechanisms in Humans. Farris S; Stempien-Otero A Circ Res; 2015 Aug; 117(6):494-7. PubMed ID: 26316605 [No Abstract] [Full Text] [Related]
19. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Trachtenberg B; Velazquez DL; Williams AR; McNiece I; Fishman J; Nguyen K; Rouy D; Altman P; Schwarz R; Mendizabal A; Oskouei B; Byrnes J; Soto V; Tracy M; Zambrano JP; Heldman AW; Hare JM Am Heart J; 2011 Mar; 161(3):487-93. PubMed ID: 21392602 [TBL] [Abstract][Full Text] [Related]
20. Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study. Kastrup J; Haack-Sørensen M; Juhl M; Harary Søndergaard R; Follin B; Drozd Lund L; Mønsted Johansen E; Ali Qayyum A; Bruun Mathiasen A; Jørgensen E; Helqvist S; Jørgen Elberg J; Bruunsgaard H; Ekblond A Stem Cells Transl Med; 2017 Nov; 6(11):1963-1971. PubMed ID: 28880460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]